- IBDEI2HT ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,39806,1,3,0)
- ;;=3^Family Hx of Malig Neop of Testis
- ;;^UTILITY(U,$J,358.3,39806,1,4,0)
- ;;=4^Z80.43
- ;;^UTILITY(U,$J,358.3,39806,2)
- ;;=^5063350
- ;;^UTILITY(U,$J,358.3,39807,0)
- ;;=Z80.6^^152^2001^25
- ;;^UTILITY(U,$J,358.3,39807,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39807,1,3,0)
- ;;=3^Family Hx of Leukemia
- ;;^UTILITY(U,$J,358.3,39807,1,4,0)
- ;;=4^Z80.6
- ;;^UTILITY(U,$J,358.3,39807,2)
- ;;=^5063354
- ;;^UTILITY(U,$J,358.3,39808,0)
- ;;=Z80.8^^152^2001^30
- ;;^UTILITY(U,$J,358.3,39808,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39808,1,3,0)
- ;;=3^Family Hx of Malig Neop of Organs/Systems
- ;;^UTILITY(U,$J,358.3,39808,1,4,0)
- ;;=4^Z80.8
- ;;^UTILITY(U,$J,358.3,39808,2)
- ;;=^5063356
- ;;^UTILITY(U,$J,358.3,39809,0)
- ;;=Z81.8^^152^2001^35
- ;;^UTILITY(U,$J,358.3,39809,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39809,1,3,0)
- ;;=3^Family Hx of Mental/Behavioral Disorders
- ;;^UTILITY(U,$J,358.3,39809,1,4,0)
- ;;=4^Z81.8
- ;;^UTILITY(U,$J,358.3,39809,2)
- ;;=^5063363
- ;;^UTILITY(U,$J,358.3,39810,0)
- ;;=Z82.3^^152^2001^42
- ;;^UTILITY(U,$J,358.3,39810,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39810,1,3,0)
- ;;=3^Family Hx of Stroke
- ;;^UTILITY(U,$J,358.3,39810,1,4,0)
- ;;=4^Z82.3
- ;;^UTILITY(U,$J,358.3,39810,2)
- ;;=^5063367
- ;;^UTILITY(U,$J,358.3,39811,0)
- ;;=Z82.49^^152^2001^24
- ;;^UTILITY(U,$J,358.3,39811,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39811,1,3,0)
- ;;=3^Family Hx of Ischemic Heart Disease/Circulatory System
- ;;^UTILITY(U,$J,358.3,39811,1,4,0)
- ;;=4^Z82.49
- ;;^UTILITY(U,$J,358.3,39811,2)
- ;;=^5063369
- ;;^UTILITY(U,$J,358.3,39812,0)
- ;;=Z82.5^^152^2001^14
- ;;^UTILITY(U,$J,358.3,39812,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39812,1,3,0)
- ;;=3^Family Hx of Asthma/Chronic Lower Respiratory Diseases
- ;;^UTILITY(U,$J,358.3,39812,1,4,0)
- ;;=4^Z82.5
- ;;^UTILITY(U,$J,358.3,39812,2)
- ;;=^5063370
- ;;^UTILITY(U,$J,358.3,39813,0)
- ;;=Z82.61^^152^2001^13
- ;;^UTILITY(U,$J,358.3,39813,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39813,1,3,0)
- ;;=3^Family Hx of Arthritis
- ;;^UTILITY(U,$J,358.3,39813,1,4,0)
- ;;=4^Z82.61
- ;;^UTILITY(U,$J,358.3,39813,2)
- ;;=^5063371
- ;;^UTILITY(U,$J,358.3,39814,0)
- ;;=Z82.69^^152^2001^37
- ;;^UTILITY(U,$J,358.3,39814,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39814,1,3,0)
- ;;=3^Family Hx of Musculoskeletal System/Connective Tissue
- ;;^UTILITY(U,$J,358.3,39814,1,4,0)
- ;;=4^Z82.69
- ;;^UTILITY(U,$J,358.3,39814,2)
- ;;=^5063373
- ;;^UTILITY(U,$J,358.3,39815,0)
- ;;=Z83.3^^152^2001^20
- ;;^UTILITY(U,$J,358.3,39815,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39815,1,3,0)
- ;;=3^Family Hx of Diabetes Mellitus
- ;;^UTILITY(U,$J,358.3,39815,1,4,0)
- ;;=4^Z83.3
- ;;^UTILITY(U,$J,358.3,39815,2)
- ;;=^5063379
- ;;^UTILITY(U,$J,358.3,39816,0)
- ;;=Z83.2^^152^2001^16
- ;;^UTILITY(U,$J,358.3,39816,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39816,1,3,0)
- ;;=3^Family Hx of Blood/Immune Mechanism Diseases
- ;;^UTILITY(U,$J,358.3,39816,1,4,0)
- ;;=4^Z83.2
- ;;^UTILITY(U,$J,358.3,39816,2)
- ;;=^5063378
- ;;^UTILITY(U,$J,358.3,39817,0)
- ;;=Z82.71^^152^2001^40
- ;;^UTILITY(U,$J,358.3,39817,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39817,1,3,0)
- ;;=3^Family Hx of Polycystic Kidney
- ;;^UTILITY(U,$J,358.3,39817,1,4,0)
- ;;=4^Z82.71
- ;;^UTILITY(U,$J,358.3,39817,2)
- ;;=^321531
- ;;^UTILITY(U,$J,358.3,39818,0)
- ;;=Z82.1^^152^2001^15
- ;;^UTILITY(U,$J,358.3,39818,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,39818,1,3,0)
- ;;=3^Family Hx of Blindness/Visual Loss
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2HT 3820 printed Feb 18, 2025@23:55:28 Page 2
- IBDEI2HT ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,39806,1,3,0)
- +2 ;;=3^Family Hx of Malig Neop of Testis
- +3 ;;^UTILITY(U,$J,358.3,39806,1,4,0)
- +4 ;;=4^Z80.43
- +5 ;;^UTILITY(U,$J,358.3,39806,2)
- +6 ;;=^5063350
- +7 ;;^UTILITY(U,$J,358.3,39807,0)
- +8 ;;=Z80.6^^152^2001^25
- +9 ;;^UTILITY(U,$J,358.3,39807,1,0)
- +10 ;;=^358.31IA^4^2
- +11 ;;^UTILITY(U,$J,358.3,39807,1,3,0)
- +12 ;;=3^Family Hx of Leukemia
- +13 ;;^UTILITY(U,$J,358.3,39807,1,4,0)
- +14 ;;=4^Z80.6
- +15 ;;^UTILITY(U,$J,358.3,39807,2)
- +16 ;;=^5063354
- +17 ;;^UTILITY(U,$J,358.3,39808,0)
- +18 ;;=Z80.8^^152^2001^30
- +19 ;;^UTILITY(U,$J,358.3,39808,1,0)
- +20 ;;=^358.31IA^4^2
- +21 ;;^UTILITY(U,$J,358.3,39808,1,3,0)
- +22 ;;=3^Family Hx of Malig Neop of Organs/Systems
- +23 ;;^UTILITY(U,$J,358.3,39808,1,4,0)
- +24 ;;=4^Z80.8
- +25 ;;^UTILITY(U,$J,358.3,39808,2)
- +26 ;;=^5063356
- +27 ;;^UTILITY(U,$J,358.3,39809,0)
- +28 ;;=Z81.8^^152^2001^35
- +29 ;;^UTILITY(U,$J,358.3,39809,1,0)
- +30 ;;=^358.31IA^4^2
- +31 ;;^UTILITY(U,$J,358.3,39809,1,3,0)
- +32 ;;=3^Family Hx of Mental/Behavioral Disorders
- +33 ;;^UTILITY(U,$J,358.3,39809,1,4,0)
- +34 ;;=4^Z81.8
- +35 ;;^UTILITY(U,$J,358.3,39809,2)
- +36 ;;=^5063363
- +37 ;;^UTILITY(U,$J,358.3,39810,0)
- +38 ;;=Z82.3^^152^2001^42
- +39 ;;^UTILITY(U,$J,358.3,39810,1,0)
- +40 ;;=^358.31IA^4^2
- +41 ;;^UTILITY(U,$J,358.3,39810,1,3,0)
- +42 ;;=3^Family Hx of Stroke
- +43 ;;^UTILITY(U,$J,358.3,39810,1,4,0)
- +44 ;;=4^Z82.3
- +45 ;;^UTILITY(U,$J,358.3,39810,2)
- +46 ;;=^5063367
- +47 ;;^UTILITY(U,$J,358.3,39811,0)
- +48 ;;=Z82.49^^152^2001^24
- +49 ;;^UTILITY(U,$J,358.3,39811,1,0)
- +50 ;;=^358.31IA^4^2
- +51 ;;^UTILITY(U,$J,358.3,39811,1,3,0)
- +52 ;;=3^Family Hx of Ischemic Heart Disease/Circulatory System
- +53 ;;^UTILITY(U,$J,358.3,39811,1,4,0)
- +54 ;;=4^Z82.49
- +55 ;;^UTILITY(U,$J,358.3,39811,2)
- +56 ;;=^5063369
- +57 ;;^UTILITY(U,$J,358.3,39812,0)
- +58 ;;=Z82.5^^152^2001^14
- +59 ;;^UTILITY(U,$J,358.3,39812,1,0)
- +60 ;;=^358.31IA^4^2
- +61 ;;^UTILITY(U,$J,358.3,39812,1,3,0)
- +62 ;;=3^Family Hx of Asthma/Chronic Lower Respiratory Diseases
- +63 ;;^UTILITY(U,$J,358.3,39812,1,4,0)
- +64 ;;=4^Z82.5
- +65 ;;^UTILITY(U,$J,358.3,39812,2)
- +66 ;;=^5063370
- +67 ;;^UTILITY(U,$J,358.3,39813,0)
- +68 ;;=Z82.61^^152^2001^13
- +69 ;;^UTILITY(U,$J,358.3,39813,1,0)
- +70 ;;=^358.31IA^4^2
- +71 ;;^UTILITY(U,$J,358.3,39813,1,3,0)
- +72 ;;=3^Family Hx of Arthritis
- +73 ;;^UTILITY(U,$J,358.3,39813,1,4,0)
- +74 ;;=4^Z82.61
- +75 ;;^UTILITY(U,$J,358.3,39813,2)
- +76 ;;=^5063371
- +77 ;;^UTILITY(U,$J,358.3,39814,0)
- +78 ;;=Z82.69^^152^2001^37
- +79 ;;^UTILITY(U,$J,358.3,39814,1,0)
- +80 ;;=^358.31IA^4^2
- +81 ;;^UTILITY(U,$J,358.3,39814,1,3,0)
- +82 ;;=3^Family Hx of Musculoskeletal System/Connective Tissue
- +83 ;;^UTILITY(U,$J,358.3,39814,1,4,0)
- +84 ;;=4^Z82.69
- +85 ;;^UTILITY(U,$J,358.3,39814,2)
- +86 ;;=^5063373
- +87 ;;^UTILITY(U,$J,358.3,39815,0)
- +88 ;;=Z83.3^^152^2001^20
- +89 ;;^UTILITY(U,$J,358.3,39815,1,0)
- +90 ;;=^358.31IA^4^2
- +91 ;;^UTILITY(U,$J,358.3,39815,1,3,0)
- +92 ;;=3^Family Hx of Diabetes Mellitus
- +93 ;;^UTILITY(U,$J,358.3,39815,1,4,0)
- +94 ;;=4^Z83.3
- +95 ;;^UTILITY(U,$J,358.3,39815,2)
- +96 ;;=^5063379
- +97 ;;^UTILITY(U,$J,358.3,39816,0)
- +98 ;;=Z83.2^^152^2001^16
- +99 ;;^UTILITY(U,$J,358.3,39816,1,0)
- +100 ;;=^358.31IA^4^2
- +101 ;;^UTILITY(U,$J,358.3,39816,1,3,0)
- +102 ;;=3^Family Hx of Blood/Immune Mechanism Diseases
- +103 ;;^UTILITY(U,$J,358.3,39816,1,4,0)
- +104 ;;=4^Z83.2
- +105 ;;^UTILITY(U,$J,358.3,39816,2)
- +106 ;;=^5063378
- +107 ;;^UTILITY(U,$J,358.3,39817,0)
- +108 ;;=Z82.71^^152^2001^40
- +109 ;;^UTILITY(U,$J,358.3,39817,1,0)
- +110 ;;=^358.31IA^4^2
- +111 ;;^UTILITY(U,$J,358.3,39817,1,3,0)
- +112 ;;=3^Family Hx of Polycystic Kidney
- +113 ;;^UTILITY(U,$J,358.3,39817,1,4,0)
- +114 ;;=4^Z82.71
- +115 ;;^UTILITY(U,$J,358.3,39817,2)
- +116 ;;=^321531
- +117 ;;^UTILITY(U,$J,358.3,39818,0)
- +118 ;;=Z82.1^^152^2001^15
- +119 ;;^UTILITY(U,$J,358.3,39818,1,0)
- +120 ;;=^358.31IA^4^2
- +121 ;;^UTILITY(U,$J,358.3,39818,1,3,0)
- +122 ;;=3^Family Hx of Blindness/Visual Loss
